nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—CYP2C8—Mometasone—atopic dermatitis	0.0525	0.114	CbGbCtD
Pazopanib—ABCG2—Hydrocortisone—atopic dermatitis	0.0315	0.0686	CbGbCtD
Pazopanib—CYP2C8—Loratadine—atopic dermatitis	0.0301	0.0657	CbGbCtD
Pazopanib—CYP3A4—Pimecrolimus—atopic dermatitis	0.0281	0.0612	CbGbCtD
Pazopanib—ABCB1—Tacrolimus—atopic dermatitis	0.0279	0.0607	CbGbCtD
Pazopanib—CYP1A2—Diphenhydramine—atopic dermatitis	0.0233	0.0508	CbGbCtD
Pazopanib—ABCB1—Loratadine—atopic dermatitis	0.0204	0.0445	CbGbCtD
Pazopanib—ABCG2—Dexamethasone—atopic dermatitis	0.0196	0.0426	CbGbCtD
Pazopanib—CYP2D6—Diphenhydramine—atopic dermatitis	0.0192	0.0419	CbGbCtD
Pazopanib—CYP2D6—Loratadine—atopic dermatitis	0.0192	0.0419	CbGbCtD
Pazopanib—ABCB1—Methylprednisolone—atopic dermatitis	0.0187	0.0407	CbGbCtD
Pazopanib—CYP2C8—Hydrocortisone—atopic dermatitis	0.0168	0.0365	CbGbCtD
Pazopanib—CYP3A4—Tacrolimus—atopic dermatitis	0.0167	0.0364	CbGbCtD
Pazopanib—FGF1—dermis—atopic dermatitis	0.0138	0.136	CbGeAlD
Pazopanib—CYP3A4—Loratadine—atopic dermatitis	0.0122	0.0266	CbGbCtD
Pazopanib—ABCB1—Betamethasone—atopic dermatitis	0.0121	0.0264	CbGbCtD
Pazopanib—ABCB1—Prednisolone—atopic dermatitis	0.012	0.0261	CbGbCtD
Pazopanib—ABCB1—Hydrocortisone—atopic dermatitis	0.0113	0.0247	CbGbCtD
Pazopanib—ABCB1—Prednisone—atopic dermatitis	0.0113	0.0246	CbGbCtD
Pazopanib—CYP3A4—Methylprednisolone—atopic dermatitis	0.0112	0.0244	CbGbCtD
Pazopanib—CYP2C8—Dexamethasone—atopic dermatitis	0.0104	0.0227	CbGbCtD
Pazopanib—CYP3A4—Triamcinolone—atopic dermatitis	0.00847	0.0185	CbGbCtD
Pazopanib—FGFR3—skin epidermis—atopic dermatitis	0.00837	0.0826	CbGeAlD
Pazopanib—CYP3A4—Betamethasone—atopic dermatitis	0.00727	0.0158	CbGbCtD
Pazopanib—CYP3A4—Prednisolone—atopic dermatitis	0.00717	0.0156	CbGbCtD
Pazopanib—ABCB1—Dexamethasone—atopic dermatitis	0.00706	0.0154	CbGbCtD
Pazopanib—CYP3A4—Hydrocortisone—atopic dermatitis	0.0068	0.0148	CbGbCtD
Pazopanib—CYP3A4—Prednisone—atopic dermatitis	0.00677	0.0148	CbGbCtD
Pazopanib—CYP2D6—Dexamethasone—atopic dermatitis	0.00665	0.0145	CbGbCtD
Pazopanib—FGF1—skin epidermis—atopic dermatitis	0.00581	0.0572	CbGeAlD
Pazopanib—FGFR2—skin epidermis—atopic dermatitis	0.00548	0.054	CbGeAlD
Pazopanib—CYP3A4—Dexamethasone—atopic dermatitis	0.00423	0.00921	CbGbCtD
Pazopanib—KIT—skin epidermis—atopic dermatitis	0.00381	0.0375	CbGeAlD
Pazopanib—MAP3K9—head—atopic dermatitis	0.00286	0.0282	CbGeAlD
Pazopanib—FGF1—neck—atopic dermatitis	0.00278	0.0274	CbGeAlD
Pazopanib—FGFR2—neck—atopic dermatitis	0.00262	0.0259	CbGeAlD
Pazopanib—FGFR3—skin of body—atopic dermatitis	0.00259	0.0256	CbGeAlD
Pazopanib—FLT1—neck—atopic dermatitis	0.00243	0.024	CbGeAlD
Pazopanib—TAOK1—head—atopic dermatitis	0.00215	0.0212	CbGeAlD
Pazopanib—KDR—neck—atopic dermatitis	0.00206	0.0203	CbGeAlD
Pazopanib—SH2B3—head—atopic dermatitis	0.00202	0.0199	CbGeAlD
Pazopanib—AURKC—head—atopic dermatitis	0.00199	0.0196	CbGeAlD
Pazopanib—KIT—neck—atopic dermatitis	0.00182	0.018	CbGeAlD
Pazopanib—FGF1—skin of body—atopic dermatitis	0.0018	0.0177	CbGeAlD
Pazopanib—PDGFRB—neck—atopic dermatitis	0.00178	0.0175	CbGeAlD
Pazopanib—STK16—head—atopic dermatitis	0.00172	0.017	CbGeAlD
Pazopanib—LYN—head—atopic dermatitis	0.0017	0.0168	CbGeAlD
Pazopanib—FGFR2—skin of body—atopic dermatitis	0.0017	0.0167	CbGeAlD
Pazopanib—RIOK2—head—atopic dermatitis	0.00169	0.0167	CbGeAlD
Pazopanib—FGFR3—head—atopic dermatitis	0.00169	0.0167	CbGeAlD
Pazopanib—MAP3K19—head—atopic dermatitis	0.00168	0.0165	CbGeAlD
Pazopanib—BMPR1B—head—atopic dermatitis	0.00168	0.0165	CbGeAlD
Pazopanib—EPHB6—skin of body—atopic dermatitis	0.00156	0.0153	CbGeAlD
Pazopanib—STK36—head—atopic dermatitis	0.00152	0.015	CbGeAlD
Pazopanib—PI4KB—head—atopic dermatitis	0.0015	0.0148	CbGeAlD
Pazopanib—LIMK2—head—atopic dermatitis	0.00147	0.0145	CbGeAlD
Pazopanib—FLT4—head—atopic dermatitis	0.00132	0.013	CbGeAlD
Pazopanib—PIP4K2C—head—atopic dermatitis	0.00131	0.013	CbGeAlD
Pazopanib—CSF1R—skin of body—atopic dermatitis	0.0013	0.0128	CbGeAlD
Pazopanib—MAP3K2—head—atopic dermatitis	0.00125	0.0123	CbGeAlD
Pazopanib—KIT—skin of body—atopic dermatitis	0.00118	0.0116	CbGeAlD
Pazopanib—FGF1—head—atopic dermatitis	0.00117	0.0116	CbGeAlD
Pazopanib—PDGFRB—skin of body—atopic dermatitis	0.00115	0.0114	CbGeAlD
Pazopanib—FGFR2—head—atopic dermatitis	0.00111	0.0109	CbGeAlD
Pazopanib—FLT1—head—atopic dermatitis	0.00103	0.0101	CbGeAlD
Pazopanib—EPHB6—head—atopic dermatitis	0.00102	0.01	CbGeAlD
Pazopanib—STK10—head—atopic dermatitis	0.000972	0.00959	CbGeAlD
Pazopanib—TAOK3—head—atopic dermatitis	0.000969	0.00955	CbGeAlD
Pazopanib—PDGFRA—head—atopic dermatitis	0.000963	0.00949	CbGeAlD
Pazopanib—MAP2K5—head—atopic dermatitis	0.000868	0.00856	CbGeAlD
Pazopanib—KDR—head—atopic dermatitis	0.000868	0.00856	CbGeAlD
Pazopanib—CSF1R—head—atopic dermatitis	0.000847	0.00836	CbGeAlD
Pazopanib—KIT—head—atopic dermatitis	0.00077	0.00759	CbGeAlD
Pazopanib—PDGFRB—head—atopic dermatitis	0.000752	0.00741	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Desonide—atopic dermatitis	0.000602	0.0934	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Desonide—atopic dermatitis	0.000602	0.0934	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Fluocinonide—atopic dermatitis	0.000482	0.0748	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Fluocinonide—atopic dermatitis	0.000482	0.0748	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000468	0.0727	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Fluocinolone Acetonide—atopic dermatitis	0.000468	0.0727	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Mometasone—atopic dermatitis	0.000374	0.058	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Mometasone—atopic dermatitis	0.000374	0.058	CbGdCrCtD
Pazopanib—CYP2D6—head—atopic dermatitis	0.00029	0.00286	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Hydrocortisone—atopic dermatitis	0.000237	0.0367	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Hydrocortisone—atopic dermatitis	0.000237	0.0367	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Methylprednisolone—atopic dermatitis	0.000223	0.0346	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Methylprednisolone—atopic dermatitis	0.000223	0.0346	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Betamethasone—atopic dermatitis	0.00022	0.0341	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Dexamethasone—atopic dermatitis	0.00022	0.0341	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Triamcinolone—atopic dermatitis	0.000215	0.0333	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Triamcinolone—atopic dermatitis	0.000215	0.0333	CbGdCrCtD
Pazopanib—ABCB1—head—atopic dermatitis	0.000208	0.00205	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Prednisone—atopic dermatitis	0.000204	0.0316	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisone—atopic dermatitis	0.000204	0.0316	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisolone—atopic dermatitis	0.000199	0.0309	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisolone—atopic dermatitis	0.000199	0.0309	CbGdCrCtD
Pazopanib—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.00017	0.000657	CcSEcCtD
Pazopanib—Pancreatitis—Prednisone—atopic dermatitis	0.000168	0.000648	CcSEcCtD
Pazopanib—Vomiting—Mometasone—atopic dermatitis	0.000168	0.000647	CcSEcCtD
Pazopanib—Rash—Mometasone—atopic dermatitis	0.000166	0.000642	CcSEcCtD
Pazopanib—Dermatitis—Mometasone—atopic dermatitis	0.000166	0.000641	CcSEcCtD
Pazopanib—Abdominal pain—Tacrolimus—atopic dermatitis	0.000166	0.00064	CcSEcCtD
Pazopanib—Headache—Mometasone—atopic dermatitis	0.000165	0.000638	CcSEcCtD
Pazopanib—Erythema—Prednisolone—atopic dermatitis	0.000164	0.000634	CcSEcCtD
Pazopanib—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000164	0.000633	CcSEcCtD
Pazopanib—Eye disorder—Methylprednisolone—atopic dermatitis	0.000162	0.000625	CcSEcCtD
Pazopanib—Mental disorder—Hydrocortisone—atopic dermatitis	0.000161	0.000623	CcSEcCtD
Pazopanib—Cardiac disorder—Methylprednisolone—atopic dermatitis	0.000161	0.00062	CcSEcCtD
Pazopanib—Malnutrition—Hydrocortisone—atopic dermatitis	0.00016	0.000619	CcSEcCtD
Pazopanib—Erythema—Hydrocortisone—atopic dermatitis	0.00016	0.000619	CcSEcCtD
Pazopanib—Bradycardia—Betamethasone—atopic dermatitis	0.00016	0.000619	CcSEcCtD
Pazopanib—Bradycardia—Dexamethasone—atopic dermatitis	0.00016	0.000619	CcSEcCtD
Pazopanib—Neutropenia—Prednisone—atopic dermatitis	0.00016	0.000618	CcSEcCtD
Pazopanib—Haemoglobin—Betamethasone—atopic dermatitis	0.000158	0.000611	CcSEcCtD
Pazopanib—Haemoglobin—Dexamethasone—atopic dermatitis	0.000158	0.000611	CcSEcCtD
Pazopanib—Haemorrhage—Dexamethasone—atopic dermatitis	0.000157	0.000608	CcSEcCtD
Pazopanib—Haemorrhage—Betamethasone—atopic dermatitis	0.000157	0.000608	CcSEcCtD
Pazopanib—Angiopathy—Methylprednisolone—atopic dermatitis	0.000157	0.000606	CcSEcCtD
Pazopanib—Nausea—Mometasone—atopic dermatitis	0.000157	0.000605	CcSEcCtD
Pazopanib—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.000156	0.000602	CcSEcCtD
Pazopanib—Weight decreased—Prednisone—atopic dermatitis	0.000155	0.000598	CcSEcCtD
Pazopanib—Vision blurred—Prednisolone—atopic dermatitis	0.000155	0.000598	CcSEcCtD
Pazopanib—Mental disorder—Methylprednisolone—atopic dermatitis	0.000152	0.000586	CcSEcCtD
Pazopanib—Erythema—Triamcinolone—atopic dermatitis	0.000151	0.000583	CcSEcCtD
Pazopanib—Erythema—Methylprednisolone—atopic dermatitis	0.000151	0.000582	CcSEcCtD
Pazopanib—Malnutrition—Methylprednisolone—atopic dermatitis	0.000151	0.000582	CcSEcCtD
Pazopanib—Asthenia—Tacrolimus—atopic dermatitis	0.000151	0.000581	CcSEcCtD
Pazopanib—Acute coronary syndrome—Prednisone—atopic dermatitis	0.000151	0.000581	CcSEcCtD
Pazopanib—Myocardial infarction—Prednisone—atopic dermatitis	0.00015	0.000578	CcSEcCtD
Pazopanib—Pruritus—Tacrolimus—atopic dermatitis	0.000148	0.000573	CcSEcCtD
Pazopanib—Dysgeusia—Triamcinolone—atopic dermatitis	0.000148	0.000571	CcSEcCtD
Pazopanib—Syncope—Prednisolone—atopic dermatitis	0.000147	0.000569	CcSEcCtD
Pazopanib—Eye disorder—Betamethasone—atopic dermatitis	0.000147	0.000568	CcSEcCtD
Pazopanib—Eye disorder—Dexamethasone—atopic dermatitis	0.000147	0.000568	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisolone—atopic dermatitis	0.000144	0.000557	CcSEcCtD
Pazopanib—Syncope—Hydrocortisone—atopic dermatitis	0.000144	0.000555	CcSEcCtD
Pazopanib—Diarrhoea—Tacrolimus—atopic dermatitis	0.000144	0.000554	CcSEcCtD
Pazopanib—Angiopathy—Dexamethasone—atopic dermatitis	0.000143	0.000551	CcSEcCtD
Pazopanib—Angiopathy—Betamethasone—atopic dermatitis	0.000143	0.000551	CcSEcCtD
Pazopanib—Hypertension—Prednisolone—atopic dermatitis	0.000142	0.000547	CcSEcCtD
Pazopanib—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000141	0.000544	CcSEcCtD
Pazopanib—Bradycardia—Prednisone—atopic dermatitis	0.00014	0.000539	CcSEcCtD
Pazopanib—Alopecia—Dexamethasone—atopic dermatitis	0.000139	0.000537	CcSEcCtD
Pazopanib—Alopecia—Betamethasone—atopic dermatitis	0.000139	0.000537	CcSEcCtD
Pazopanib—Dizziness—Tacrolimus—atopic dermatitis	0.000139	0.000536	CcSEcCtD
Pazopanib—Hypertension—Hydrocortisone—atopic dermatitis	0.000138	0.000535	CcSEcCtD
Pazopanib—Haemoglobin—Prednisone—atopic dermatitis	0.000138	0.000532	CcSEcCtD
Pazopanib—Haemorrhage—Prednisone—atopic dermatitis	0.000137	0.000529	CcSEcCtD
Pazopanib—Erythema—Dexamethasone—atopic dermatitis	0.000137	0.000529	CcSEcCtD
Pazopanib—Erythema—Betamethasone—atopic dermatitis	0.000137	0.000529	CcSEcCtD
Pazopanib—Myalgia—Hydrocortisone—atopic dermatitis	0.000137	0.000527	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.000136	0.000524	CcSEcCtD
Pazopanib—Syncope—Triamcinolone—atopic dermatitis	0.000135	0.000523	CcSEcCtD
Pazopanib—Syncope—Methylprednisolone—atopic dermatitis	0.000135	0.000522	CcSEcCtD
Pazopanib—Connective tissue disorder—Prednisone—atopic dermatitis	0.000135	0.00052	CcSEcCtD
Pazopanib—Oedema—Prednisolone—atopic dermatitis	0.000134	0.000517	CcSEcCtD
Pazopanib—Vomiting—Tacrolimus—atopic dermatitis	0.000133	0.000515	CcSEcCtD
Pazopanib—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000133	0.000512	CcSEcCtD
Pazopanib—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000132	0.000511	CcSEcCtD
Pazopanib—Rash—Tacrolimus—atopic dermatitis	0.000132	0.000511	CcSEcCtD
Pazopanib—Dermatitis—Tacrolimus—atopic dermatitis	0.000132	0.00051	CcSEcCtD
Pazopanib—Shock—Prednisolone—atopic dermatitis	0.000132	0.000509	CcSEcCtD
Pazopanib—Cough—Triamcinolone—atopic dermatitis	0.000132	0.000509	CcSEcCtD
Pazopanib—Headache—Tacrolimus—atopic dermatitis	0.000131	0.000508	CcSEcCtD
Pazopanib—Oedema—Hydrocortisone—atopic dermatitis	0.000131	0.000505	CcSEcCtD
Pazopanib—Hypertension—Triamcinolone—atopic dermatitis	0.00013	0.000503	CcSEcCtD
Pazopanib—Hypertension—Methylprednisolone—atopic dermatitis	0.00013	0.000502	CcSEcCtD
Pazopanib—Infection—Hydrocortisone—atopic dermatitis	0.00013	0.000502	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00013	0.0005	CcSEcCtD
Pazopanib—Shock—Hydrocortisone—atopic dermatitis	0.000129	0.000497	CcSEcCtD
Pazopanib—Myalgia—Triamcinolone—atopic dermatitis	0.000129	0.000496	CcSEcCtD
Pazopanib—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000128	0.000496	CcSEcCtD
Pazopanib—Myalgia—Methylprednisolone—atopic dermatitis	0.000128	0.000495	CcSEcCtD
Pazopanib—Arthralgia—Methylprednisolone—atopic dermatitis	0.000128	0.000495	CcSEcCtD
Pazopanib—Eye disorder—Prednisone—atopic dermatitis	0.000128	0.000495	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000127	0.000492	CcSEcCtD
Pazopanib—Flushing—Prednisone—atopic dermatitis	0.000127	0.000491	CcSEcCtD
Pazopanib—Skin disorder—Hydrocortisone—atopic dermatitis	0.000127	0.000491	CcSEcCtD
Pazopanib—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000127	0.000489	CcSEcCtD
Pazopanib—Dry mouth—Triamcinolone—atopic dermatitis	0.000126	0.000485	CcSEcCtD
Pazopanib—Anorexia—Hydrocortisone—atopic dermatitis	0.000125	0.000482	CcSEcCtD
Pazopanib—Nausea—Tacrolimus—atopic dermatitis	0.000125	0.000481	CcSEcCtD
Pazopanib—Angiopathy—Prednisone—atopic dermatitis	0.000124	0.00048	CcSEcCtD
Pazopanib—Oedema—Triamcinolone—atopic dermatitis	0.000123	0.000476	CcSEcCtD
Pazopanib—Syncope—Dexamethasone—atopic dermatitis	0.000123	0.000474	CcSEcCtD
Pazopanib—Syncope—Betamethasone—atopic dermatitis	0.000123	0.000474	CcSEcCtD
Pazopanib—Infection—Triamcinolone—atopic dermatitis	0.000122	0.000473	CcSEcCtD
Pazopanib—Infection—Methylprednisolone—atopic dermatitis	0.000122	0.000472	CcSEcCtD
Pazopanib—Shock—Triamcinolone—atopic dermatitis	0.000121	0.000468	CcSEcCtD
Pazopanib—Insomnia—Prednisolone—atopic dermatitis	0.000121	0.000468	CcSEcCtD
Pazopanib—Alopecia—Prednisone—atopic dermatitis	0.000121	0.000468	CcSEcCtD
Pazopanib—Shock—Methylprednisolone—atopic dermatitis	0.000121	0.000467	CcSEcCtD
Pazopanib—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000121	0.000466	CcSEcCtD
Pazopanib—Loss of consciousness—Betamethasone—atopic dermatitis	0.00012	0.000465	CcSEcCtD
Pazopanib—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00012	0.000465	CcSEcCtD
Pazopanib—Paraesthesia—Prednisolone—atopic dermatitis	0.00012	0.000465	CcSEcCtD
Pazopanib—Mental disorder—Prednisone—atopic dermatitis	0.00012	0.000464	CcSEcCtD
Pazopanib—Skin disorder—Methylprednisolone—atopic dermatitis	0.000119	0.000461	CcSEcCtD
Pazopanib—Erythema—Prednisone—atopic dermatitis	0.000119	0.000461	CcSEcCtD
Pazopanib—Malnutrition—Prednisone—atopic dermatitis	0.000119	0.000461	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000119	0.00046	CcSEcCtD
Pazopanib—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000119	0.00046	CcSEcCtD
Pazopanib—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000119	0.000459	CcSEcCtD
Pazopanib—Insomnia—Hydrocortisone—atopic dermatitis	0.000118	0.000457	CcSEcCtD
Pazopanib—Hypertension—Betamethasone—atopic dermatitis	0.000118	0.000457	CcSEcCtD
Pazopanib—Hypertension—Dexamethasone—atopic dermatitis	0.000118	0.000457	CcSEcCtD
Pazopanib—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000118	0.000454	CcSEcCtD
Pazopanib—Myalgia—Betamethasone—atopic dermatitis	0.000117	0.00045	CcSEcCtD
Pazopanib—Myalgia—Dexamethasone—atopic dermatitis	0.000117	0.00045	CcSEcCtD
Pazopanib—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000115	0.000445	CcSEcCtD
Pazopanib—Pain—Prednisolone—atopic dermatitis	0.000115	0.000443	CcSEcCtD
Pazopanib—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000114	0.000439	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000113	0.000436	CcSEcCtD
Pazopanib—Fatigue—Hydrocortisone—atopic dermatitis	0.000113	0.000436	CcSEcCtD
Pazopanib—Vision blurred—Prednisone—atopic dermatitis	0.000112	0.000434	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000112	0.000434	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000112	0.000433	CcSEcCtD
Pazopanib—Pain—Hydrocortisone—atopic dermatitis	0.000112	0.000432	CcSEcCtD
Pazopanib—Oedema—Dexamethasone—atopic dermatitis	0.000112	0.000432	CcSEcCtD
Pazopanib—Oedema—Betamethasone—atopic dermatitis	0.000112	0.000432	CcSEcCtD
Pazopanib—Insomnia—Triamcinolone—atopic dermatitis	0.000111	0.00043	CcSEcCtD
Pazopanib—Insomnia—Methylprednisolone—atopic dermatitis	0.000111	0.000429	CcSEcCtD
Pazopanib—Infection—Betamethasone—atopic dermatitis	0.000111	0.000429	CcSEcCtD
Pazopanib—Infection—Dexamethasone—atopic dermatitis	0.000111	0.000429	CcSEcCtD
Pazopanib—Paraesthesia—Triamcinolone—atopic dermatitis	0.000111	0.000427	CcSEcCtD
Pazopanib—Paraesthesia—Methylprednisolone—atopic dermatitis	0.00011	0.000426	CcSEcCtD
Pazopanib—Anaemia—Prednisone—atopic dermatitis	0.00011	0.000426	CcSEcCtD
Pazopanib—Shock—Betamethasone—atopic dermatitis	0.00011	0.000425	CcSEcCtD
Pazopanib—Shock—Dexamethasone—atopic dermatitis	0.00011	0.000425	CcSEcCtD
Pazopanib—Dyspnoea—Triamcinolone—atopic dermatitis	0.00011	0.000424	CcSEcCtD
Pazopanib—Nervous system disorder—Dexamethasone—atopic dermatitis	0.00011	0.000423	CcSEcCtD
Pazopanib—Nervous system disorder—Betamethasone—atopic dermatitis	0.00011	0.000423	CcSEcCtD
Pazopanib—Thrombocytopenia—Dexamethasone—atopic dermatitis	0.00011	0.000423	CcSEcCtD
Pazopanib—Thrombocytopenia—Betamethasone—atopic dermatitis	0.00011	0.000423	CcSEcCtD
Pazopanib—Dyspepsia—Triamcinolone—atopic dermatitis	0.000109	0.000419	CcSEcCtD
Pazopanib—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000108	0.000418	CcSEcCtD
Pazopanib—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000108	0.000417	CcSEcCtD
Pazopanib—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000108	0.000417	CcSEcCtD
Pazopanib—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000107	0.000413	CcSEcCtD
Pazopanib—Syncope—Prednisone—atopic dermatitis	0.000107	0.000413	CcSEcCtD
Pazopanib—Anorexia—Dexamethasone—atopic dermatitis	0.000107	0.000412	CcSEcCtD
Pazopanib—Anorexia—Betamethasone—atopic dermatitis	0.000107	0.000412	CcSEcCtD
Pazopanib—Fatigue—Triamcinolone—atopic dermatitis	0.000106	0.00041	CcSEcCtD
Pazopanib—Fatigue—Methylprednisolone—atopic dermatitis	0.000106	0.000409	CcSEcCtD
Pazopanib—Pain—Triamcinolone—atopic dermatitis	0.000105	0.000407	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisone—atopic dermatitis	0.000105	0.000405	CcSEcCtD
Pazopanib—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000103	0.0004	CcSEcCtD
Pazopanib—Hypertension—Prednisone—atopic dermatitis	0.000103	0.000398	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000102	0.000393	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000102	0.000393	CcSEcCtD
Pazopanib—Arthralgia—Prednisone—atopic dermatitis	0.000102	0.000392	CcSEcCtD
Pazopanib—Myalgia—Prednisone—atopic dermatitis	0.000102	0.000392	CcSEcCtD
Pazopanib—Insomnia—Betamethasone—atopic dermatitis	0.000101	0.000391	CcSEcCtD
Pazopanib—Insomnia—Dexamethasone—atopic dermatitis	0.000101	0.000391	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000101	0.00039	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000101	0.000388	CcSEcCtD
Pazopanib—Paraesthesia—Betamethasone—atopic dermatitis	0.0001	0.000388	CcSEcCtD
Pazopanib—Paraesthesia—Dexamethasone—atopic dermatitis	0.0001	0.000388	CcSEcCtD
Pazopanib—Dyspepsia—Dexamethasone—atopic dermatitis	9.85e-05	0.00038	CcSEcCtD
Pazopanib—Dyspepsia—Betamethasone—atopic dermatitis	9.85e-05	0.00038	CcSEcCtD
Pazopanib—Oedema—Prednisone—atopic dermatitis	9.74e-05	0.000376	CcSEcCtD
Pazopanib—Abdominal pain—Methylprednisolone—atopic dermatitis	9.72e-05	0.000375	CcSEcCtD
Pazopanib—Decreased appetite—Betamethasone—atopic dermatitis	9.72e-05	0.000375	CcSEcCtD
Pazopanib—Decreased appetite—Dexamethasone—atopic dermatitis	9.72e-05	0.000375	CcSEcCtD
Pazopanib—Infection—Prednisone—atopic dermatitis	9.68e-05	0.000374	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	9.66e-05	0.000373	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Betamethasone—atopic dermatitis	9.66e-05	0.000373	CcSEcCtD
Pazopanib—Fatigue—Dexamethasone—atopic dermatitis	9.64e-05	0.000372	CcSEcCtD
Pazopanib—Fatigue—Betamethasone—atopic dermatitis	9.64e-05	0.000372	CcSEcCtD
Pazopanib—Shock—Prednisone—atopic dermatitis	9.58e-05	0.00037	CcSEcCtD
Pazopanib—Pain—Betamethasone—atopic dermatitis	9.56e-05	0.000369	CcSEcCtD
Pazopanib—Pain—Dexamethasone—atopic dermatitis	9.56e-05	0.000369	CcSEcCtD
Pazopanib—Nervous system disorder—Prednisone—atopic dermatitis	9.55e-05	0.000369	CcSEcCtD
Pazopanib—Skin disorder—Prednisone—atopic dermatitis	9.46e-05	0.000365	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisone—atopic dermatitis	9.42e-05	0.000364	CcSEcCtD
Pazopanib—Asthenia—Hydrocortisone—atopic dermatitis	9.39e-05	0.000363	CcSEcCtD
Pazopanib—Anorexia—Prednisone—atopic dermatitis	9.28e-05	0.000358	CcSEcCtD
Pazopanib—Pruritus—Hydrocortisone—atopic dermatitis	9.26e-05	0.000358	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dexamethasone—atopic dermatitis	9.15e-05	0.000353	CcSEcCtD
Pazopanib—Gastrointestinal pain—Betamethasone—atopic dermatitis	9.15e-05	0.000353	CcSEcCtD
Pazopanib—Diarrhoea—Hydrocortisone—atopic dermatitis	8.96e-05	0.000346	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Prednisone—atopic dermatitis	8.87e-05	0.000343	CcSEcCtD
Pazopanib—Dizziness—Prednisolone—atopic dermatitis	8.86e-05	0.000342	CcSEcCtD
Pazopanib—Asthenia—Triamcinolone—atopic dermatitis	8.84e-05	0.000341	CcSEcCtD
Pazopanib—Abdominal pain—Betamethasone—atopic dermatitis	8.84e-05	0.000341	CcSEcCtD
Pazopanib—Abdominal pain—Dexamethasone—atopic dermatitis	8.84e-05	0.000341	CcSEcCtD
Pazopanib—Asthenia—Methylprednisolone—atopic dermatitis	8.82e-05	0.000341	CcSEcCtD
Pazopanib—Insomnia—Prednisone—atopic dermatitis	8.81e-05	0.00034	CcSEcCtD
Pazopanib—Paraesthesia—Prednisone—atopic dermatitis	8.75e-05	0.000338	CcSEcCtD
Pazopanib—Pruritus—Triamcinolone—atopic dermatitis	8.72e-05	0.000337	CcSEcCtD
Pazopanib—Pruritus—Methylprednisolone—atopic dermatitis	8.7e-05	0.000336	CcSEcCtD
Pazopanib—Dizziness—Hydrocortisone—atopic dermatitis	8.66e-05	0.000334	CcSEcCtD
Pazopanib—Dyspepsia—Prednisone—atopic dermatitis	8.57e-05	0.000331	CcSEcCtD
Pazopanib—Decreased appetite—Prednisone—atopic dermatitis	8.47e-05	0.000327	CcSEcCtD
Pazopanib—Rash—Prednisolone—atopic dermatitis	8.45e-05	0.000326	CcSEcCtD
Pazopanib—Dermatitis—Prednisolone—atopic dermatitis	8.44e-05	0.000326	CcSEcCtD
Pazopanib—Diarrhoea—Methylprednisolone—atopic dermatitis	8.42e-05	0.000325	CcSEcCtD
Pazopanib—Fatigue—Prednisone—atopic dermatitis	8.4e-05	0.000324	CcSEcCtD
Pazopanib—Headache—Prednisolone—atopic dermatitis	8.4e-05	0.000324	CcSEcCtD
Pazopanib—Vomiting—Hydrocortisone—atopic dermatitis	8.32e-05	0.000321	CcSEcCtD
Pazopanib—Rash—Hydrocortisone—atopic dermatitis	8.25e-05	0.000319	CcSEcCtD
Pazopanib—Dermatitis—Hydrocortisone—atopic dermatitis	8.25e-05	0.000318	CcSEcCtD
Pazopanib—Headache—Hydrocortisone—atopic dermatitis	8.2e-05	0.000317	CcSEcCtD
Pazopanib—Dizziness—Triamcinolone—atopic dermatitis	8.15e-05	0.000315	CcSEcCtD
Pazopanib—Dizziness—Methylprednisolone—atopic dermatitis	8.13e-05	0.000314	CcSEcCtD
Pazopanib—Asthenia—Betamethasone—atopic dermatitis	8.02e-05	0.00031	CcSEcCtD
Pazopanib—Asthenia—Dexamethasone—atopic dermatitis	8.02e-05	0.00031	CcSEcCtD
Pazopanib—Gastrointestinal pain—Prednisone—atopic dermatitis	7.96e-05	0.000307	CcSEcCtD
Pazopanib—Nausea—Prednisolone—atopic dermatitis	7.96e-05	0.000307	CcSEcCtD
Pazopanib—Pruritus—Betamethasone—atopic dermatitis	7.91e-05	0.000305	CcSEcCtD
Pazopanib—Pruritus—Dexamethasone—atopic dermatitis	7.91e-05	0.000305	CcSEcCtD
Pazopanib—Vomiting—Triamcinolone—atopic dermatitis	7.84e-05	0.000303	CcSEcCtD
Pazopanib—Vomiting—Methylprednisolone—atopic dermatitis	7.82e-05	0.000302	CcSEcCtD
Pazopanib—Nausea—Hydrocortisone—atopic dermatitis	7.78e-05	0.0003	CcSEcCtD
Pazopanib—Rash—Triamcinolone—atopic dermatitis	7.77e-05	0.0003	CcSEcCtD
Pazopanib—Dermatitis—Triamcinolone—atopic dermatitis	7.77e-05	0.0003	CcSEcCtD
Pazopanib—Rash—Methylprednisolone—atopic dermatitis	7.75e-05	0.000299	CcSEcCtD
Pazopanib—Dermatitis—Methylprednisolone—atopic dermatitis	7.75e-05	0.000299	CcSEcCtD
Pazopanib—Headache—Triamcinolone—atopic dermatitis	7.72e-05	0.000298	CcSEcCtD
Pazopanib—Headache—Methylprednisolone—atopic dermatitis	7.71e-05	0.000297	CcSEcCtD
Pazopanib—Abdominal pain—Prednisone—atopic dermatitis	7.7e-05	0.000297	CcSEcCtD
Pazopanib—Diarrhoea—Dexamethasone—atopic dermatitis	7.65e-05	0.000295	CcSEcCtD
Pazopanib—Diarrhoea—Betamethasone—atopic dermatitis	7.65e-05	0.000295	CcSEcCtD
Pazopanib—Dizziness—Betamethasone—atopic dermatitis	7.4e-05	0.000286	CcSEcCtD
Pazopanib—Dizziness—Dexamethasone—atopic dermatitis	7.4e-05	0.000286	CcSEcCtD
Pazopanib—Nausea—Triamcinolone—atopic dermatitis	7.32e-05	0.000283	CcSEcCtD
Pazopanib—Nausea—Methylprednisolone—atopic dermatitis	7.31e-05	0.000282	CcSEcCtD
Pazopanib—Vomiting—Dexamethasone—atopic dermatitis	7.11e-05	0.000275	CcSEcCtD
Pazopanib—Vomiting—Betamethasone—atopic dermatitis	7.11e-05	0.000275	CcSEcCtD
Pazopanib—Rash—Betamethasone—atopic dermatitis	7.05e-05	0.000272	CcSEcCtD
Pazopanib—Rash—Dexamethasone—atopic dermatitis	7.05e-05	0.000272	CcSEcCtD
Pazopanib—Dermatitis—Dexamethasone—atopic dermatitis	7.05e-05	0.000272	CcSEcCtD
Pazopanib—Dermatitis—Betamethasone—atopic dermatitis	7.05e-05	0.000272	CcSEcCtD
Pazopanib—Headache—Dexamethasone—atopic dermatitis	7.01e-05	0.00027	CcSEcCtD
Pazopanib—Headache—Betamethasone—atopic dermatitis	7.01e-05	0.00027	CcSEcCtD
Pazopanib—Asthenia—Prednisone—atopic dermatitis	6.99e-05	0.00027	CcSEcCtD
Pazopanib—Pruritus—Prednisone—atopic dermatitis	6.89e-05	0.000266	CcSEcCtD
Pazopanib—Diarrhoea—Prednisone—atopic dermatitis	6.66e-05	0.000257	CcSEcCtD
Pazopanib—Nausea—Betamethasone—atopic dermatitis	6.64e-05	0.000256	CcSEcCtD
Pazopanib—Nausea—Dexamethasone—atopic dermatitis	6.64e-05	0.000256	CcSEcCtD
Pazopanib—Dizziness—Prednisone—atopic dermatitis	6.44e-05	0.000249	CcSEcCtD
Pazopanib—Vomiting—Prednisone—atopic dermatitis	6.19e-05	0.000239	CcSEcCtD
Pazopanib—Rash—Prednisone—atopic dermatitis	6.14e-05	0.000237	CcSEcCtD
Pazopanib—Dermatitis—Prednisone—atopic dermatitis	6.14e-05	0.000237	CcSEcCtD
Pazopanib—Headache—Prednisone—atopic dermatitis	6.1e-05	0.000236	CcSEcCtD
Pazopanib—Nausea—Prednisone—atopic dermatitis	5.79e-05	0.000223	CcSEcCtD
Pazopanib—PDGFRB—Signaling Pathways—NPS—atopic dermatitis	1.98e-05	0.000114	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TAC1—atopic dermatitis	1.98e-05	0.000114	CbGpPWpGaD
Pazopanib—ITK—Immune System—IL6—atopic dermatitis	1.98e-05	0.000114	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—MAPK8—atopic dermatitis	1.98e-05	0.000113	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CCL5—atopic dermatitis	1.95e-05	0.000112	CbGpPWpGaD
Pazopanib—PDGFRB—Adaptive Immune System—CD4—atopic dermatitis	1.95e-05	0.000112	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NGF—atopic dermatitis	1.95e-05	0.000112	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCR3—atopic dermatitis	1.95e-05	0.000112	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TAC1—atopic dermatitis	1.94e-05	0.000112	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NPS—atopic dermatitis	1.94e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR1—Axon guidance—IL6—atopic dermatitis	1.94e-05	0.000112	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CCR5—atopic dermatitis	1.94e-05	0.000111	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CCR5—atopic dermatitis	1.93e-05	0.000111	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling by NGF—IL6—atopic dermatitis	1.93e-05	0.000111	CbGpPWpGaD
Pazopanib—LYN—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.92e-05	0.00011	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—MAPK8—atopic dermatitis	1.92e-05	0.00011	CbGpPWpGaD
Pazopanib—LYN—Adaptive Immune System—CD4—atopic dermatitis	1.91e-05	0.00011	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—MAPK8—atopic dermatitis	1.91e-05	0.00011	CbGpPWpGaD
Pazopanib—FGFR3—Innate Immune System—IL6—atopic dermatitis	1.91e-05	0.00011	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—NFKBIA—atopic dermatitis	1.91e-05	0.00011	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCR3—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL1B—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Pazopanib—FGFR3—Disease—CD4—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NGF—atopic dermatitis	1.9e-05	0.000109	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CCR5—atopic dermatitis	1.89e-05	0.000109	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL2—atopic dermatitis	1.89e-05	0.000109	CbGpPWpGaD
Pazopanib—KDR—Developmental Biology—IL6—atopic dermatitis	1.88e-05	0.000108	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL10—atopic dermatitis	1.88e-05	0.000108	CbGpPWpGaD
Pazopanib—KIT—Immune System—NFKBIA—atopic dermatitis	1.87e-05	0.000108	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CCR5—atopic dermatitis	1.84e-05	0.000106	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL5—atopic dermatitis	1.84e-05	0.000106	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL10—atopic dermatitis	1.84e-05	0.000106	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GLB1—atopic dermatitis	1.81e-05	0.000104	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NGF—atopic dermatitis	1.81e-05	0.000104	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL5—atopic dermatitis	1.81e-05	0.000104	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—NFKBIA—atopic dermatitis	1.79e-05	0.000103	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR3—atopic dermatitis	1.79e-05	0.000103	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—NFKBIA—atopic dermatitis	1.78e-05	0.000102	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—NFKBIA—atopic dermatitis	1.77e-05	0.000102	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IFNG—atopic dermatitis	1.77e-05	0.000102	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CCR5—atopic dermatitis	1.76e-05	0.000101	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	1.75e-05	0.000101	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL10—atopic dermatitis	1.75e-05	0.000101	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL10—atopic dermatitis	1.75e-05	0.0001	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CCR5—atopic dermatitis	1.74e-05	0.0001	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—MAPK8—atopic dermatitis	1.74e-05	0.0001	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADSL—atopic dermatitis	1.74e-05	9.97e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—MAPK8—atopic dermatitis	1.72e-05	9.89e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CASP8—atopic dermatitis	1.72e-05	9.89e-05	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—TNF—atopic dermatitis	1.72e-05	9.86e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—CD4—atopic dermatitis	1.71e-05	9.81e-05	CbGpPWpGaD
Pazopanib—LYN—Axon guidance—IL6—atopic dermatitis	1.71e-05	9.81e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GLB1—atopic dermatitis	1.71e-05	9.8e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—CASP8—atopic dermatitis	1.69e-05	9.71e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—MAPK8—atopic dermatitis	1.69e-05	9.69e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL18—atopic dermatitis	1.68e-05	9.65e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—CXCL8—atopic dermatitis	1.68e-05	9.63e-05	CbGpPWpGaD
Pazopanib—LCK—Hemostasis—IL2—atopic dermatitis	1.67e-05	9.58e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD8A—atopic dermatitis	1.65e-05	9.51e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADSL—atopic dermatitis	1.64e-05	9.4e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—CD4—atopic dermatitis	1.63e-05	9.37e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CCL5—atopic dermatitis	1.62e-05	9.28e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CASP8—atopic dermatitis	1.6e-05	9.22e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—NFKBIA—atopic dermatitis	1.6e-05	9.22e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL2—atopic dermatitis	1.6e-05	9.2e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CASP8—atopic dermatitis	1.6e-05	9.2e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—NFKBIA—atopic dermatitis	1.6e-05	9.18e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TAC1—atopic dermatitis	1.59e-05	9.14e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NPS—atopic dermatitis	1.59e-05	9.14e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCL5—atopic dermatitis	1.59e-05	9.12e-05	CbGpPWpGaD
Pazopanib—FGF1—Innate Immune System—IL6—atopic dermatitis	1.59e-05	9.11e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL1B—atopic dermatitis	1.58e-05	9.06e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—CD4—atopic dermatitis	1.58e-05	9.06e-05	CbGpPWpGaD
Pazopanib—LCK—Cytokine Signaling in Immune system—IL6—atopic dermatitis	1.57e-05	9.04e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL10—atopic dermatitis	1.57e-05	9.03e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL2—atopic dermatitis	1.57e-05	9.03e-05	CbGpPWpGaD
Pazopanib—LCK—Adaptive Immune System—CD4—atopic dermatitis	1.57e-05	9e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—NFKBIA—atopic dermatitis	1.57e-05	8.99e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—NFKBIA—atopic dermatitis	1.56e-05	8.98e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCR3—atopic dermatitis	1.56e-05	8.97e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling by NGF—IL6—atopic dermatitis	1.55e-05	8.89e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL10—atopic dermatitis	1.54e-05	8.84e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.51e-05	8.7e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—TNF—atopic dermatitis	1.51e-05	8.68e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCL5—atopic dermatitis	1.51e-05	8.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCL5—atopic dermatitis	1.5e-05	8.63e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NGF—atopic dermatitis	1.5e-05	8.6e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—NFKBIA—atopic dermatitis	1.49e-05	8.57e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL5—atopic dermatitis	1.48e-05	8.5e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—MAPK8—atopic dermatitis	1.47e-05	8.47e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NGF—atopic dermatitis	1.47e-05	8.44e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IFNG—atopic dermatitis	1.46e-05	8.41e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CCR5—atopic dermatitis	1.46e-05	8.36e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—MAPK8—atopic dermatitis	1.45e-05	8.31e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GLB1—atopic dermatitis	1.45e-05	8.3e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CASP8—atopic dermatitis	1.44e-05	8.28e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IFNG—atopic dermatitis	1.44e-05	8.26e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CCR5—atopic dermatitis	1.43e-05	8.21e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—CD4—atopic dermatitis	1.41e-05	8.12e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CASP8—atopic dermatitis	1.41e-05	8.11e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CCR5—atopic dermatitis	1.4e-05	8.03e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	8.01e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NGF—atopic dermatitis	1.39e-05	7.99e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—CD4—atopic dermatitis	1.39e-05	7.98e-05	CbGpPWpGaD
Pazopanib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	1.39e-05	7.97e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADSL—atopic dermatitis	1.39e-05	7.96e-05	CbGpPWpGaD
Pazopanib—FGFR1—Developmental Biology—IL6—atopic dermatitis	1.39e-05	7.96e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—MAPK8—atopic dermatitis	1.38e-05	7.94e-05	CbGpPWpGaD
Pazopanib—BMPR1B—Signaling Pathways—IL6—atopic dermatitis	1.38e-05	7.92e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IFNG—atopic dermatitis	1.36e-05	7.84e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IFNG—atopic dermatitis	1.36e-05	7.82e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CCR5—atopic dermatitis	1.36e-05	7.79e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CCR5—atopic dermatitis	1.35e-05	7.77e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL5—atopic dermatitis	1.35e-05	7.77e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL5—atopic dermatitis	1.33e-05	7.61e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—CD4—atopic dermatitis	1.32e-05	7.57e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—CD4—atopic dermatitis	1.31e-05	7.55e-05	CbGpPWpGaD
Pazopanib—FGFR2—Innate Immune System—IL6—atopic dermatitis	1.31e-05	7.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL1B—atopic dermatitis	1.31e-05	7.5e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—CD4—atopic dermatitis	1.31e-05	7.5e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL2—atopic dermatitis	1.3e-05	7.47e-05	CbGpPWpGaD
Pazopanib—KIT—Innate Immune System—IL6—atopic dermatitis	1.29e-05	7.41e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—NFKBIA—atopic dermatitis	1.28e-05	7.37e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL1B—atopic dermatitis	1.28e-05	7.37e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—CD4—atopic dermatitis	1.28e-05	7.37e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PPARA—atopic dermatitis	1.28e-05	7.36e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—CXCL8—atopic dermatitis	1.28e-05	7.35e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL2—atopic dermatitis	1.28e-05	7.34e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL10—atopic dermatitis	1.26e-05	7.25e-05	CbGpPWpGaD
Pazopanib—FLT4—Signaling Pathways—IL6—atopic dermatitis	1.26e-05	7.25e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	1.25e-05	7.21e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NGF—atopic dermatitis	1.25e-05	7.2e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—NFKBIA—atopic dermatitis	1.23e-05	7.09e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NGF—atopic dermatitis	1.23e-05	7.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IFNG—atopic dermatitis	1.23e-05	7.04e-05	CbGpPWpGaD
Pazopanib—FGFR1—Innate Immune System—IL6—atopic dermatitis	1.22e-05	7.03e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL2—atopic dermatitis	1.22e-05	7.03e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Innate Immune System—IL6—atopic dermatitis	1.22e-05	7.01e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCR5—atopic dermatitis	1.22e-05	7e-05	CbGpPWpGaD
Pazopanib—LYN—Developmental Biology—IL6—atopic dermatitis	1.22e-05	7e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL1B—atopic dermatitis	1.22e-05	6.99e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—CD4—atopic dermatitis	1.22e-05	6.99e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL1B—atopic dermatitis	1.21e-05	6.97e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—CD4—atopic dermatitis	1.21e-05	6.97e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL2—atopic dermatitis	1.21e-05	6.97e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—NFKBIA—atopic dermatitis	1.21e-05	6.96e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL2—atopic dermatitis	1.21e-05	6.95e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IFNG—atopic dermatitis	1.2e-05	6.9e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—MAPK8—atopic dermatitis	1.2e-05	6.88e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCR5—atopic dermatitis	1.19e-05	6.86e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—CD4—atopic dermatitis	1.18e-05	6.8e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—MAPK8—atopic dermatitis	1.18e-05	6.76e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PPARA—atopic dermatitis	1.17e-05	6.74e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—CD4—atopic dermatitis	1.16e-05	6.66e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CASP8—atopic dermatitis	1.16e-05	6.65e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	6.61e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NFKBIA—atopic dermatitis	1.15e-05	6.59e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—CXCL8—atopic dermatitis	1.14e-05	6.57e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—MAPK8—atopic dermatitis	1.13e-05	6.47e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—MAPK8—atopic dermatitis	1.12e-05	6.41e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.12e-05	6.41e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—CXCL8—atopic dermatitis	1.11e-05	6.4e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—MAPK8—atopic dermatitis	1.11e-05	6.4e-05	CbGpPWpGaD
Pazopanib—FGFR3—Immune System—IL6—atopic dermatitis	1.11e-05	6.39e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Innate Immune System—IL6—atopic dermatitis	1.1e-05	6.32e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL1B—atopic dermatitis	1.09e-05	6.28e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—CD4—atopic dermatitis	1.09e-05	6.28e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL2—atopic dermatitis	1.09e-05	6.28e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL2—atopic dermatitis	1.09e-05	6.26e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PPARA—atopic dermatitis	1.09e-05	6.24e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL5—atopic dermatitis	1.09e-05	6.24e-05	CbGpPWpGaD
Pazopanib—LYN—Innate Immune System—IL6—atopic dermatitis	1.08e-05	6.18e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL1B—atopic dermatitis	1.07e-05	6.15e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.07e-05	6.14e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL2—atopic dermatitis	1.07e-05	6.13e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL2—atopic dermatitis	1.07e-05	6.12e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—CXCL8—atopic dermatitis	1.06e-05	6.11e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	1.05e-05	6.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NFKBIA—atopic dermatitis	1.03e-05	5.94e-05	CbGpPWpGaD
Pazopanib—FGFR3—Disease—IL6—atopic dermatitis	1.03e-05	5.9e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL2—atopic dermatitis	1.02e-05	5.84e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NFKBIA—atopic dermatitis	1.01e-05	5.81e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—MAPK8—atopic dermatitis	1.01e-05	5.78e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NGF—atopic dermatitis	1.01e-05	5.78e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—MAPK8—atopic dermatitis	1e-05	5.76e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IFNG—atopic dermatitis	9.84e-06	5.65e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—MAPK8—atopic dermatitis	9.82e-06	5.64e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—MAPK8—atopic dermatitis	9.81e-06	5.63e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCR5—atopic dermatitis	9.79e-06	5.62e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—CD4—atopic dermatitis	9.5e-06	5.46e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—atopic dermatitis	9.41e-06	5.41e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—MAPK8—atopic dermatitis	9.36e-06	5.37e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—atopic dermatitis	9.24e-06	5.31e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—atopic dermatitis	8.82e-06	5.07e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL8—atopic dermatitis	8.8e-06	5.06e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—atopic dermatitis	8.78e-06	5.04e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—atopic dermatitis	8.78e-06	5.04e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—atopic dermatitis	8.74e-06	5.02e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL8—atopic dermatitis	8.64e-06	4.97e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—atopic dermatitis	8.53e-06	4.9e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—atopic dermatitis	8.41e-06	4.83e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NFKBIA—atopic dermatitis	8.3e-06	4.77e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—atopic dermatitis	8.26e-06	4.75e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL8—atopic dermatitis	8.2e-06	4.71e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL8—atopic dermatitis	8.18e-06	4.7e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—MAPK8—atopic dermatitis	8.05e-06	4.62e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—atopic dermatitis	7.84e-06	4.5e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—atopic dermatitis	7.82e-06	4.49e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MAPK8—atopic dermatitis	7.74e-06	4.45e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—atopic dermatitis	7.65e-06	4.39e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MAPK8—atopic dermatitis	7.6e-06	4.37e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—atopic dermatitis	7.51e-06	4.31e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—atopic dermatitis	7.37e-06	4.23e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—atopic dermatitis	7.22e-06	4.15e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MAPK8—atopic dermatitis	7.22e-06	4.15e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MAPK8—atopic dermatitis	7.2e-06	4.13e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—atopic dermatitis	7.19e-06	4.13e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—atopic dermatitis	7.13e-06	4.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—atopic dermatitis	7.11e-06	4.08e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—atopic dermatitis	7.06e-06	4.06e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—atopic dermatitis	7.05e-06	4.05e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—atopic dermatitis	6.93e-06	3.98e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—atopic dermatitis	6.9e-06	3.96e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPARA—atopic dermatitis	6.75e-06	3.87e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—atopic dermatitis	6.58e-06	3.78e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—atopic dermatitis	6.56e-06	3.77e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MAPK8—atopic dermatitis	6.48e-06	3.73e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—atopic dermatitis	6.43e-06	3.69e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—atopic dermatitis	6.4e-06	3.68e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MAPK8—atopic dermatitis	6.35e-06	3.65e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—atopic dermatitis	6.27e-06	3.6e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—atopic dermatitis	6.26e-06	3.6e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—atopic dermatitis	5.97e-06	3.43e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—atopic dermatitis	5.92e-06	3.4e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—atopic dermatitis	5.91e-06	3.4e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPARA—atopic dermatitis	5.88e-06	3.38e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—atopic dermatitis	5.65e-06	3.25e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPARA—atopic dermatitis	5.54e-06	3.18e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MAPK8—atopic dermatitis	5.2e-06	2.99e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—atopic dermatitis	5.14e-06	2.95e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—atopic dermatitis	4.94e-06	2.84e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—atopic dermatitis	4.86e-06	2.79e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—atopic dermatitis	4.75e-06	2.73e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPARA—atopic dermatitis	4.69e-06	2.69e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—atopic dermatitis	4.61e-06	2.65e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—atopic dermatitis	4.6e-06	2.64e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—atopic dermatitis	4.14e-06	2.38e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—atopic dermatitis	4.05e-06	2.33e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPARA—atopic dermatitis	3.62e-06	2.08e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—atopic dermatitis	3.32e-06	1.91e-05	CbGpPWpGaD
